15 August 2025
15 August 2025
Eli Lilly said the increase brings the UK price in line with other European markets, though NHS availability will be unaffected.
The deal follows a similar billion-dollar GPCR partnership made by rival Novo Nordisk earlier this year.
Concerns around the safety profile of the chikungunya vaccine Ixchiq in elderly individuals continue as travel-related cases increase in the UK.
With multiple novel therapies expected and the treatment paradigm shifting toward earlier intervention, the market will grow rapidly.
The integration of AI into the management of IPF represents a significant advancement in the field.
Basilea expects to begin a Phase III trial with the antibiotic candidate in around 18 months.
This was found via the University of Pennsylvania Health System's published study results in July.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
